Candel Therapeutics (CADL) Prices 9M Share IPO at $8/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Candel Therapeutics (CADL) IPO Opens Flat
July 27, 2021 11:22 AM EDTToday's IPO for Candel Therapeutics, Inc. (NASDAQ: CADL) opened for trading at $8 after pricing 9,000,000 shares of common stock at a public offering price of $8.00 per share.
Jefferies, Credit Suisse, BMO Capital Markets and UBS Investment Bank are acting as joint book-running... More
